Novavax NVAX Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novavax NVAX

NVAX 7.505

-5.1%

Nov 4 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Paul Senior	1/28/2021 11:59:53 PM
	of 166

Good news on schedule: Novavax reports "more than 89% efficacy". That's overall. 95.6% effective on the original strain! (Which apparently is better than all other competitor vac's so far.) 86% for British variant. Vac can be stored at refrigerator temperatures. I'm trying to understand further. Not so effective against the SA strain (??). 60%? Similar to other company vac's in this regard?? If only 60%, then masks/social distancing can't be eliminated though if this variant spreads here (USA) ?? "The study involved more than 15,000 participants aged 18 to 84, with 27 per cent aged over 65." independent.co.uk I'll take a few more shares.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next